180 related articles for article (PubMed ID: 17674329)
1. Persistence of cell-mediated immunity to vaccinia virus.
Kim SH; Oh MD
J Infect Dis; 2007 Sep; 196(5):805-6. PubMed ID: 17674329
[No Abstract] [Full Text] [Related]
2. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
[TBL] [Abstract][Full Text] [Related]
3. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.
Kim SH; Bang JW; Park KH; Park WB; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
J Infect Dis; 2006 Aug; 194(3):377-84. PubMed ID: 16826487
[TBL] [Abstract][Full Text] [Related]
4. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
[TBL] [Abstract][Full Text] [Related]
5. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
Treanor J; Wu H; Liang H; Topham DJ
Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
[TBL] [Abstract][Full Text] [Related]
6. New data in a 200-year investigation.
Bray M
Clin Infect Dis; 2004 Jan; 38(1):90-1. PubMed ID: 14679453
[No Abstract] [Full Text] [Related]
7. [Experiments on the challenge of the antivaccinial transfer immunity of cell cultures by infection with variola virus. (Evaluation of the antivariola potency of smallpox vaccines)].
Stickl H
Zentralbl Bakteriol Orig; 1968; 208(4):473-85. PubMed ID: 4329545
[No Abstract] [Full Text] [Related]
8. Bioterrorism. Smallpox vaccinations: how much protection remains?
Cohen J
Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
[No Abstract] [Full Text] [Related]
9. Age distribution for T cell reactivity to vaccinia virus in a healthy population.
Hsieh SM; Pan SC; Chen SY; Huang PF; Chang SC
Clin Infect Dis; 2004 Jan; 38(1):86-9. PubMed ID: 14679452
[TBL] [Abstract][Full Text] [Related]
10. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
McCurdy LH; Larkin BD; Martin JE; Graham BS
Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
[TBL] [Abstract][Full Text] [Related]
11. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
Kim SH; Choi SJ; Park WB; Kim HB; Kim NJ; Oh MD; Choe KW
Vaccine; 2007 Aug; 25(33):6287-91. PubMed ID: 17597266
[TBL] [Abstract][Full Text] [Related]
12. [Smallpx vaccination].
Just M
Schweiz Med Wochenschr; 1968 Mar; 98(13):495-503. PubMed ID: 5700509
[No Abstract] [Full Text] [Related]
13. IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.
Jones T
Curr Opin Mol Ther; 2008 Aug; 10(4):407-17. PubMed ID: 18683106
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer.
Wiser I; Orr N; Kaufman B; Segev S; Smetana Z; Bialik A; Epstein N; Mendelson E; Catane R; Cohen D
J Infect Dis; 2010 May; 201(10):1527-34. PubMed ID: 20388035
[TBL] [Abstract][Full Text] [Related]
17. Development of vaccination immunity in hospital personnel revaccinated at three-year intervals.
Nyerges G; Hollós I; Losonczy G; Erdös L; Petrás G
Acta Microbiol Acad Sci Hung; 1972; 19(1):63-8. PubMed ID: 4651044
[No Abstract] [Full Text] [Related]
18. Serological Immunity to Smallpox in New South Wales, Australia.
Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R
Viruses; 2020 May; 12(5):. PubMed ID: 32443405
[TBL] [Abstract][Full Text] [Related]
19. Persistence of vaccinia at the site of smallpox vaccination.
Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
Clin Infect Dis; 2008 Jan; 46(1):101-2. PubMed ID: 18171221
[TBL] [Abstract][Full Text] [Related]
20. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
